Satovsky Asset Management’s Alpha Tau Medical DRTS Stock Holding History

Satovsky Asset Management’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$461K	Sell	36,636 -4,070	-10%	-$36.9K	0.07%	39
2026 Q1	$288K	Sell	40,706 -12,900	-24%	-$91.1K	0.05%	55
2025 Q4	$265K	Hold	53,606	–	–	0.05%	59
2025 Q3	$242K	Hold	53,606	–	–	0.05%	53
2025 Q2	$167K	Hold	53,606	–	–	0.04%	64
2025 Q1	$135K	Hold	53,606	–	–	0.03%	55
2024 Q4	$166K	Hold	53,606	–	–	0.04%	53
2024 Q3	$128K	Hold	53,606	–	–	0.03%	55
2024 Q2	$136K	Buy	53,606 +5,012	+10%	+$12.8K	0.03%	51
2024 Q1	$143K	Sell	48,594 -9,836	-17%	-$30.2K	0.04%	49
2023 Q4	$176K	Buy	+58,430	New	+$188K	0.05%	48

Other funds holding DRTS

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Satovsky Asset Management's DRTS Position: Q2 2026 in Review

Satovsky Asset Management reduced its Alpha Tau Medical (DRTS) stake by 10% in Q2 2026, selling an estimated $36.9K and leaving 36,636 shares worth $461K. The position accounts for 0.07% of the portfolio, ranked #39.

Satovsky Asset Management first reported a position in DRTS in Q4 2023 and has held it in 11 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

Satovsky Asset Management held 36,636 shares of Alpha Tau Medical worth $461K as of Q2 2026.
Satovsky Asset Management sold 4,070 Alpha Tau Medical shares in Q2 2026, an estimated $36.9K.
Alpha Tau Medical made up 0.07% of Satovsky Asset Management's portfolio in Q2 2026, its #39 holding.
Satovsky Asset Management first reported a position in Alpha Tau Medical in Q4 2023 and has held it in 11 quarters since.
74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Satovsky Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.